Skip to content

Clinical trials

Completed Immunoglobulin Light-chain Amyloidosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoglobulin Light-chain Amyloidosis Status: Completed Country / region: United States Clear all

94 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
20011
20023
20032
20042
20054
20063
20077
20088
20093
20103
20112
20123
20133
20142
20152
20162
20172
20184
20192
20202
20213
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed94

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Medical Center7
Mayo Clinic6
Memorial Sloan Kettering Cancer Center6
Fred Hutchinson Cancer Center5
National Cancer Institute (NCI)5
Northwestern University4
SWOG Cancer Research Network4
University of Tennessee4
Jonsson Comprehensive Cancer Center3
Prothena Biosciences Ltd.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoglobulin Light-chain Amyloidosis94
Multiple Myeloma60
Neoplasms, Plasma Cell43
Leukemia, Lymphocytic, Chronic, B-Cell41
Lymphoma, Large B-Cell, Diffuse39
Burkitt Lymphoma38
Lymphoma, Follicular38
Lymphoma, Mantle-Cell38
Lymphoma, Non-Hodgkin38
Precursor Cell Lymphoblastic Leukemia-Lymphoma38

Trials

Showing 1 to 25 of 94. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.